HGHongshan Ge

Hongshan Ge

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Hongshan Ge has a total of 102 co-authors. Here are the top co-authors by number of shared publications:

  • Qi Zhu

    A Reproductive Medicine Center, The Affiliated Taizhou People’s Hospital of Nanjing Medical University, Taizhou School of Clinical Medicine, Nanjing Medical University

    12 shared publications
  • Yu Xiang

    Reproduction Medicine Centre, The Affiliated Taizhou People’s Hospital of Nanjing Medical University, Taizhou, China

    11 shared publications
  • Jieyu Cai

    Reproduction Medicine Centre, The Affiliated Taizhou People’s Hospital of Nanjing Medical University, Taizhou, People’s Republic of China

    10 shared publications
  • Na Liang

    Reproduction Medicine Centre, The Affiliated Taizhou People’s Hospital of Nanjing Medical University, Taizhou, People’s Republic of China

    10 shared publications
  • Linglin Weng

    Reproduction Medicine Centre, The Affiliated Taizhou People’s Hospital of Nanjing Medical University, Taizhou, People’s Republic of China

    9 shared publications
  • Tianyue Xu

    Reproduction Medicine Centre, The Affiliated Taizhou People's Hospital of Nanjing Medical University, Taizhou, China

    8 shared publications

Latest Publications

  • Open Access

    Follicular development impairment in polyendocrine metabolic ovarian syndrome: multidimensional pathophysiological networks and frontier therapeutic targets

    by Qiucheng Jia, Shuli Zhang, Lixin Zhang, Guangzong Zhao, Qi Zhu, Hongshan Ge

    Polyendocrine metabolic ovarian syndrome (PMOS) is a prevalent endocrine-metabolic disorder characterised by follicular arrest, anovulation, and elevated androgen levels. This review transcends single-dimensional analyses of PMOS pathology from neuroendocrine or metabolic perspectives, proposing an integrated multi-layered network model to systematically elucidate the pathological mechanisms underlying follicular arrest. Post-pubertal dysfunction of the hypothalamic-pituitary-ovarian axis interacts with systemic metabolic dysregulation, jointly establishing an ovarian microenvironment characterised by hyperandrogenism, hyperinsulinaemia, and chronic inflammation. This environment further induces self-reinforcing vicious cycles within follicles, manifesting as impaired granulosa-oocyte communication, immunometabolic reprogramming (e.g., M1 macrophage polarisation), and organelle stress (including mitochondrial dysfunction and endoplasmic reticulum stress). This localised cycle is consolidated and amplified by higher-level regulatory factors—including developmental epigenetic programming, the gut-brain-ovary axis, and circadian rhythms—ultimately establishing a pathologically entrenched state. Finally, this network-based understanding informs future research pathways, focusing on how emerging strategies—such as multi-omics integration, artificial intelligence, and stem cell secretome studies—can advance phenotype-directed precision interventions. This review aims to provide a systematic, dynamic theoretical framework for understanding the complex pathogenesis of PMOS and its potential therapeutic targets.

  • Open Access

    Lipotoxicity-induced ER-mitochondrial hypercoupling activates the mtDNA-cGAS-STING-NF-κB axis to drive follicular arrest in metabolically compromised PCOS

    by Mingrui Xue, Qi Zhu, Shuli Zhang, Guangzong Zhao, Xiaoqi Hong, Di Pang, Yue Xu, Xiaolu Li, Yuxin Liu, Ying Li, et al.

    Polycystic ovary syndrome (PCOS) represents a major cause of anovulatory infertility worldwide, yet the mechanistic nexus linking metabolic perturbations to follicular microenvironment deterioration remains elusive. This study uncovers a novel pathogenic axis wherein lipotoxicity in metabolically compromised PCOS (M-PCOS) patients—irrespective of hyperandrogenemia status—disrupts organelle homeostasis to drive follicular arrest. Integrated analyses of human follicular samples and functional validation in palmitic acid (PA)-treated granulosa cells reveal that lipotoxic stress induces endoplasmic reticulum (ER) stress, triggering ER-mitochondrial hypercoupling and pathological calcium flux. This cascade culminates in mitochondrial permeability transition pore (mPTP)-dependent release of mitochondrial DNA (mtDNA) into the cytosol, where it serves as a potent damage-associated molecular pattern (DAMP) that activates the cGAS-STING-NF-κB inflammatory pathway. Critically, we establish that this pathway operates independently of hyperandrogenemia and represents a core mechanism of granulosa cell dysfunction in M-PCOS. Genetic or pharmacological inhibition of mtDNA release (cyclosporine A), STING signaling (C-176), or ER stress (TUDCA) effectively suppressed the inflammatory cascade and restored cellular homeostasis. Most significantly, melatonin emerged as a superior therapeutic candidate, preserving organelle architecture, preventing calcium dysregulation, blocking mtDNA release, and attenuating inflammation both in vitro and in a PCOS mouse model. These findings redefine our understanding of M-PCOS pathogenesis by establishing lipotoxicity-induced organelle dysfunction as a central driver of follicular arrest, and position melatonin as a clinically translatable therapeutic agent for rescuing follicular development in metabolic PCOS—a population with notoriously poor response to conventional ovulation induction therapies.

  • Open Access

    CD36-driven mtDNA release activates cGAS-STING to induce lipotoxic senescence in granulosa cells: a metabolic-inflammatory nexus in PCOS follicular arrest

    by Xiaoqi Hong, Qi Zhu, Di Pang, Yu Xiang, Sisi Xu, Xiaofang Zhang, Guangzong Zhao, Mingrui Xue, Ying Li, Yue Xu, et al.

  • Open Access

    Mendelian randomization in ovarian research: applications in PCOS, ovarian aging, and assisted reproductive technology

    by Ling Lin, Siyuan Liu, Yu Xiang, Hongshan Ge

    Ovarian disorders such as polycystic ovary syndrome (PCOS) and primary ovarian insufficiency (POI) have complex etiologies that are difficult to disentangle using observational studies. Mendelian randomization (MR) offers a powerful approach to identify causal drivers of these conditions, with direct implications for assisted reproductive technology (ART), but its application is blocked by the ART phenotype gap, namely the absence of large-scale GWAS for cycle-specific outcomes. This review synthesizes a conceptual framework to navigate this gap. In the near term, researchers can use existing genetic data through two complementary strategies, upstream exposure analysis and proxy outcome analysis, both requiring rigorous validation and sensitivity testing. In the long term, the field must build deeply phenotyped ART genomic consortia with standardized data and ethical governance. This approach enables causal hypothesis generation using existing data, while recognizing that definitive evidence will require deeply phenotyped consortia in the future.

  • Open Access

    Mediating role of the systemic immune-inflammation index in obesity-induced glycolipid dysmetabolism and compromised IVF/ICSI outcomes in polycystic ovary syndrome: A retrospective cohort study

    by Xiaofang Mmed Zhang, Ling Mmed Lin, Hongshan Ge

    : This study aims to investigate the mediating role of the systemic immune-inflammation index (SII) in the relationship between obesity-related glycolipid indices and in vitro fertilization/intracytoplasmic sperm injection (IVF/ICSI) outcomes in women with polycystic ovary syndrome (PCOS). A total of 598 women diagnosed with PCOS according to the Rotterdam criteria and undergoing their first IVF/ICSI cycle at the Reproduction Medicine Center, Taizhou People’s Hospital Affiliated with Nanjing Medical University, Jiangsu, China between January 2021 and December 2023 were included. Key exposures included obesity-related metabolic indices (e.g., triglyceride to high-density lipoprotein ratio [TG/HDL], homeostasis model assessment of insulin resistance [HOMA-IR]) and the SII. The primary outcome was the live birth rate per initiated cycle. Associations were evaluated using multivariate generalized linear models, and causal mediation analysis was performed to quantify the proportion of the effect mediated by the SII. Higher TG/HDL, total cholesterol to HDL ratio (TC/HDL), low-density lipoprotein to HDL ratio (LDL/HDL), and HOMA-IR levels showed dose-dependent negative correlations with oocyte yield, fertilization rate, embryo quality, and live birth rate (all P < .05). An elevated SII was an independent predictor of a reduced live birth rate (β = −0.08, P = .008) and mediated 8.8% to 10.7% of the adverse effects of dyslipidemia (via TC/HDL and LDL/HDL) on live birth. This study shows that the SII is statistically linked to and potentially mediates the connection between metabolic dysfunction and poor IVF/ICSI outcomes in PCOS. Integrated strategies targeting both metabolism and inflammation may optimize fertility success in this population.


  • Open Access

    Upregulation of mitoNEET disrupts granulosa cell proliferation, apoptosis and mitochondrial homeostasis : a possible pathogenesis of follicular dysplasia in PCOS

    by Na Liang, Qi Zhu, Xia Wang, Jieyu Cai, Linglin Weng, Mingrui Xue, Xiaoqi Hong, Hongshan Ge

    Polycystic ovary syndrome (PCOS), a leading cause of anovulatory infertility, is characterized by arrested follicular development due to imbalanced prolife

  • Open Access

    Cell-free DNA in female infertility: from pathological mechanisms to clinical biomarkers

    by Ling Lin, Xinyue Zhang, Siyuan Liu, Hongshan Ge

    Female infertility, accounting for 40–50% of infertility cases globally, underscores the urgent need for non-invasive biomarkers to guide early intervention. Cell-free DNA (cfDNA)—released via apoptosis, necrosis, or active secretion—has emerged as a dynamic molecular reflector of tissue pathophysiology. This review synthesizes recent advances in cfDNA biology and their clinical applications in female infertility. Mechanistically, cfDNA drives inflammation, oxidative stress, and neutrophil extracellular traps (NETs), exacerbating dysfunction in polycystic ovary syndrome (PCOS), endometriosis (EMs), and premature ovarian insufficiency (POI). Clinically, cfDNA characteristics in follicular fluid or plasma serve as diagnostic-prognostic tools: reduced mitochondrial cfDNA (cf-mtDNA) in PCOS signifies oocyte mitochondrial damage; elevated long-fragment ratios in EMs/POI reflect chronic inflammation; and low cfDNA integrity in assisted reproductive technology (ART) predicts poor embryo quality. Despite challenges in standardization and ethics, future integration with multi-omics platforms is poised to translate cfDNA analysis into precision reproductive medicine.

  • Open Access

    Identifying critical windows of air pollution exposure and semen quality: A cross-sectional study in Chinese fertile men

    by Jialin Feng, Yan Yuan, Yuting Cheng, Peihao Wu, Yixuan Yan, Qi Liu, Feng Wu, Jing Wei, Hongshan Ge, Qiuqin Tang, et al.

    Although human studies on the hazard that air pollution represents to male reproductive health, there are wide variations in exposure concentration, key components, semen quality indicators and the identification of susceptible exposure windows. The study aimed to further explore the relationship between air pollution and semen quality and the more accurate sensitive exposure windows. We investigated a cross-sectional study consisting of 1554 fertile men from Nanjing, China and evaluated their exposure to PM10, PM2.5, CO, SO2, NO2 and O3 in the air. Multiple linear regression was utilized to estimate the correlation between weekly air pollution exposure and semen quality, as well as weighted quantile sum (WQS) regression and bayesian kernel machine regression (BKMR) for the effect of mixtures. We also established the distributed lag non-linear model to delineate exposure-lag-response relationship. Our analysis linked PM2.5 exposure at week 10 to reduced total motility (β = - 2.06, 95% CI: (- 3.71, - 0.41)) and progressive motility (β = - 1.79, 95% CI: (- 3.23, - 0.34)). WQS regression showed co-exposure inversely correlated with total motility (β = - 1.49, 95% CI: (- 2.63, - 0.35)) and progressive motility (β = - 1.27, 95% CI: (- 2.30, - 0.25)) at week 11, where PM2.5 contributed the most. A great lagged impact resulting from PM2.5 on sperm motility peaked 10 to 11 weeks after exposure. We also found that PM2.5 exposure at week 10 increased the risk of having below-referenced progressive motility (< 32%) by the method of BKMR. Based on these results, the early stage of spermatogenesis (from week 10 to week 11 before semen collection), was recognized as the susceptible exposure window. Furthermore, BKMR analysis suggested co-exposure to major components of the primary contributor, PM2.5, during this period were negatively correlated with sperm motility, including NO3-, NH4+, SO42-, black carbon and organic matter, and SO42- was the most weighted composition. In both the single pollutant models and the multi-pollutants models, PM2.5 and its chemical components inversely correlated with sperm motility in a relatively early window (from week 10 to week 11 before semen collection) which was identified to be more sensitive to air pollution.


  • Iron dysmetabolism in ovarian follicles: implications for oocyte quality and embryo development in endometriosis

    by Yu Xiang, Yang Zhang, Xia Wang, Tianyue Xu, Cen Xu, Lixin Zhang, Shu Zhou, Qi Zhu, Jieyu Cai, Linglin Weng, et al.


  • Open Access

    Hyperandrogenism-mediated YAP activation drives ovarian inflammation and pyroptosis in PCOS: implications for follicular dysfunction

    by Tianyue Xu, Yu Xiang, Zichao Huang, Qi Zhu, Honghui Wu, Jieyu Cai, Linglin Weng, Hongshan Ge

    Hyperandrogenism and persistent chronic inflammation significantly contribute to ovarian dysfunction in polycystic ovary syndrome (PCOS). Although the exact connection between hyperandrogenism and inflammation in PCOS remains unclear, the Hippo pathway, also seems to be involved in the inflammatory response through YAP. An in-vivo PCOS model of mice was constructed with dehydroepiandrosterone (DHEA) and YAP inhibitor Verteporfin (VP). YAP, inflammation and pyroptosis levels of ovarian tissues were detected in mice models. An in-vitro PCOS model of KGN cells was constructed with testosterone, and YAP was knocked down by lentivirus. Increased levels of YAP in the ovarian tissues of the DHEA-treated mice were observed, alongside elevations in inflammation and pyroptosis levels, whereas Verteporfin reversed these alterations. The findings in KGN cells demonstrated that testosterone treatment results in elevation of YAP, inflammation and pyroptosis levels in granulosa cells. However, knocking down YAP in KGN cells curtailed testosterone-induced inflammation and pyroptosis. Hyperandrogenism in PCOS promotes ovarian inflammation by upregulating nuclear YAP, disrupting the inflammatory microenvironment, leading to abnormal ovarian pyroptosis, and ultimately impairing follicular function.